{"transactions":[{"id":3019172,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI","position":1,"cik":"0000882104","reported_name":"PDL BIOPHARMA, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-01T21:52:17.000Z","date":"2020-10-01","kind":"other","acquired":false,"shares":8667397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the separation of the Issuer from the Reporting Person on October 1, 2020, the Reporting Person distributed all of the shares of common stock of the Issuer in the form of a dividend to its stockholders."},{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the separation of the Issuer from the Reporting Person on October 1, 2020, the Reporting Person distributed all of the shares of common stock of the Issuer in the form of a dividend to its stockholders."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-026691","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882104/000089924320026691/doc4.xml","form_type":"4"}},{"id":3019171,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI","position":1,"cik":"0000882104","reported_name":"PDL BIOPHARMA, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-01T21:52:17.000Z","date":"2020-09-29","kind":"purchase","acquired":true,"shares":8703,"price":11.16,"value":97125.48,"ownership":{"direct":true},"balance_after":8667397,"source":{"system":"sec-edgar","filing":"0000899243-20-026691","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000089924320026691/doc4.xml","form_type":"4"}},{"id":3135901,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI","position":1,"cik":"0000882104","reported_name":"PDL BIOPHARMA, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-26T20:43:05.000Z","date":"2020-05-21","kind":"other","acquired":false,"shares":13333334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution in-kind of the shares formerly held by the Reporting Person to its stockholders for no consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-014185","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000089924320014185/doc4.xml","form_type":"4"}},{"id":3496378,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI","position":1,"cik":"0000882104","reported_name":"PDL BIOPHARMA, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (Right to Buy)","published_at":"2019-06-10T22:16:19.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":1666667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Securities Purchase Agreement, dated as of April 10, 2019, by and among the Issuer, the Reporting Person and the other parties thereto, on June 10, 2019, the Reporting Person purchased 6,666,667 shares of Common Stock of the Issuer, at a price of $4.50 per share, and received warrants to purchase up to an additional 1,666,667 shares of Common Stock for an aggregate purchase price of approximately $30.0 million."}],"balance_after":1666667,"derivative":{"exercise_price":6.38,"exercise_date":"2019-12-10","expiration_date":"2026-06-10","underlying":"Common Stock","underlying_shares":1666667},"source":{"system":"sec-edgar","filing":"0000899243-19-016240","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882104/000089924319016240/doc4.xml","form_type":"4"}},{"id":3496377,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI","position":1,"cik":"0000882104","reported_name":"PDL BIOPHARMA, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-10T22:16:19.000Z","date":"2019-06-10","kind":"purchase","acquired":true,"shares":6666667,"price":4.5,"value":30000001.5,"ownership":{"direct":true},"balance_after":13333334,"source":{"system":"sec-edgar","filing":"0000899243-19-016240","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000089924319016240/doc4.xml","form_type":"4"}}]}